Stephen F. Betz - Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Stephen F. Betz - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Stephen F. Betz for Crinetics Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 68.6K $3.53M $51.50 Sep 10, 2024 Direct
Stock Option (right to buy) 87K Mar 4, 2024 Direct Common Stock

Transactions reported by Stephen F. Betz for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.